|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compositions.
|
|
gptkbp:applicationNumber
|
10/703,052
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:class
|
A61K
|
|
gptkbp:clinicalTrials
|
NCT00012345
|
|
gptkbp:contains
|
active pharmaceutical ingredient
|
|
gptkbp:dosageForm
|
tablet
|
|
gptkbp:evaluates
|
demonstrated in clinical trials
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
September 14, 2024
|
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
|
gptkbp:filingCountry
|
gptkb:USA
|
|
gptkbp:filingDate
|
March 29, 2004
|
|
gptkbp:future_plans
|
Phase III
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,406 C8
|
|
gptkbp:internationalClassification
|
C07D
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:jurisdiction
|
gptkb:United_States
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:marketedAs
|
BrandName
|
|
gptkbp:nonPatentCitation
|
Journal of Medicinal Chemistry
|
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
|
gptkbp:patentInventor
|
20 years
|
|
gptkbp:patentNumber
|
6,789,406
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 29, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:research_areas
|
anti-cancer agent
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:route
|
oral
|
|
gptkbp:safetyFeatures
|
well-tolerated
|
|
gptkbp:status
|
active
|
|
gptkbp:subclass
|
A61P
|
|
gptkbp:targets
|
solid tumors
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|